Actively Recruiting
Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer
Led by Centre Hospitalier Emile Roux · Updated on 2026-02-11
260
Participants Needed
1
Research Sites
150 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The diagnosis of cancer can be a major trigger for new sleep problems, especially insomnia, in people who did not have sleep issues before. Insomnia may appear early in the care pathway and can continue over time, often interacting with other physical or emotional symptoms. The main goal of this preliminary study is to describe how insomnia develops during the first months after a cancer diagnosis in patients who had no sleep problems at the time of diagnosis. This will be done through regular follow-up over time. A secondary aim is to identify the factors that may contribute to the onset or persistence of insomnia, such as the cancer treatments patients receive, as well as any medical or non-medical therapies used to manage sleep difficulties. The study will also look at whether patients who develop sleep problems are referred to psychologists trained in specific therapies for insomnia, and how well they follow and adhere to these treatments.
CONDITIONS
Official Title
Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of metastatic or non-metastatic cancer
- Cancer treated with intravenous chemotherapy and/or immunotherapy administered intravenously or subcutaneously
- Age 18 years or older
- Ability to read and understand French
- Patient covered by a social security system
- Signed informed consent
You will not qualify if you...
- SCI questionnaire score less than 16
- Diagnosed or controlled sleep disorders
- Presence of severe cognitive disorders (e.g., Alzheimer's disease) or major psychiatric disorders (e.g., psychosis), as noted in the medical record, observed at recruitment, or reported by the patient
- Patient in an emergency situation, or subject to a legal protection measure (guardianship, curatorship, or judicial protection) and unable to provide consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
12 boulevard du Dr Chantemesse
Le Puy-en-Velay, France, 43000
Actively Recruiting
Research Team
E
Emilie GADEA, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here